About this trial
The goal of this study is to: partner with Respiratory Health Association and determine barriers and unmet smoking cessation treatment needs from leaders in behavioral health organizations, treatment programs and adults who smoke (AWS) in Chicago. This will be accomplished by establishing a community advisory board (CAB) and pilot testing a community-informed smoking cessation treatment within a community behavioral health organization to determine its feasibility after addressing implementation issues.
Eligibility criteria
Qualifiers
Identify as someone who currently smokes combustible cigarettes (at least 1 cigarette per day) on each day for the past month
Report interest in quitting cigarettes (at least 6/10 scale in interest of quitting)
Age 18 or older, ability to understand the English language, willing and able to provide informed consent
Stable residence and contact information throughout the follow up period
Disqualifiers
Non-daily or intermittent cigarette use
No interest in quitting smoking
Unstable residence/not staying in Chicago for duration of study period
Current untreated severe substance use disorder (with the exception of tobacco use) or past-year serious untreated psychiatric illness (e.g. schizophrenia, bipolar disorder, obsessive compulsive disorder, unspecified psychosis, past-year suicide attempt)
Trial design
Treatments tested in this trial
- Enhanced Courage to Quit
Treatment groups
Sponsors and collaborators
University of Chicago
Lead sponsor
Respiratory Health Association
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator